~~<i id='610D97E201'><strike id='610D97E201'><tt id='610D97E201'><pre id='610D97E201'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：hotspot 2025-09-07 21:56:43 - browse：9

Limor Appelbaum, radiation oncologist and a researcher working on the effort to predict pancreatic cancer for early detection, using AI analysis of vast amounts of electronic health records. -- health coverage from STAT — Suzanne Kreiter/Globe staff

Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late.

Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.

Only 11 percent of people diagnosed with pancreatic cancer are alive five years later.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Merck CEO won’t testify in Senate, citing no expertise in drug prices

focus

hotspot

focus

HealthsecretaryXavierBecerrareceivesanupdatedCovid-19boosterinSeptember.DrewAngerer/GettyImagesWASHI

WSS

Study points to new risk in gene therapy death of Terry Horgan

Lawsuit highlights wrinkle for disputes over surprise medical bills

The Karikó problem: Lessons for funding basic research

Lawsuit highlights wrinkle for disputes over surprise medical bills

Vertex non

Investment in vaccine development is lagging, report finds

hotspot

leisure time

focus

New air purifier tech could be key to improving indoor air quality

The United States is paying nearly triple for new Covid vaccines

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Malaria cases in Florida and Texas: Here’s what you need to know

IVG is promising — but it won’t replace IVF quite yet

Activists slam private health insurers over coverage restrictions

RSV injection headlines need to be accurate for good uptake

Activists slam private health insurers over coverage restrictions

Zyn nicotine pouches become unlikely player in latest culture war

focus

Medicare innovation center doesn’t save money, experts say

RSV injection headlines need to be accurate for good uptake

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Reconstructing family trees of blood cells may help predict disease

CRISPR base editing slashes cholesterol levels in monkeys

European officials brace for rough respiratory virus season

focus

focus

hotspot

focus